174 related articles for article (PubMed ID: 38202341)
41. Silver Nanoparticles Enhance Oxidative Stress, Inflammation, and Apoptosis in Liver and Kidney Tissues: Potential Protective Role of Thymoquinone.
Salama B; Alzahrani KJ; Alghamdi KS; Al-Amer O; Hassan KE; Elhefny MA; Albarakati AJA; Alharthi F; Althagafi HA; Al Sberi H; Amin HK; Lokman MS; Alsharif KF; Albrakati A; Abdel Moneim AE; Kassab RB; Fathalla AS
Biol Trace Elem Res; 2023 Jun; 201(6):2942-2954. PubMed ID: 36018545
[TBL] [Abstract][Full Text] [Related]
42. Thymoquinone Inhibition of Chemokines in TNF-α-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells.
Adinew GM; Messeha S; Taka E; Mochona B; Redda KK; Soliman KFA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373025
[TBL] [Abstract][Full Text] [Related]
43. Coating of chitosan on poly D,L-lactic-co-glycolic acid thymoquinone nanoparticles enhances the anti-tumor activity in triple-negative breast cancer.
Gao J; Kumari A; Zeng XA; Chan S; Farooq MA; Alee M; Khan SH; Rahaman A; He S; Xin X; Mehmood T
Front Chem; 2023; 11():1044953. PubMed ID: 36846852
[TBL] [Abstract][Full Text] [Related]
44. Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis.
Shanmugam MK; Ahn KS; Hsu A; Woo CC; Yuan Y; Tan KHB; Chinnathambi A; Alahmadi TA; Alharbi SA; Koh APF; Arfuso F; Huang RY; Lim LHK; Sethi G; Kumar AP
Front Pharmacol; 2018; 9():1294. PubMed ID: 30564115
[TBL] [Abstract][Full Text] [Related]
45. Thymoquinone Nanoparticle Induces Apoptosis and Cell Migration Retardation through Modulating of SUMOylation Process Genes in Breast Cancer Cell Line.
Sohrabi B; Qadbeigi M; Sabouni F; Hamta A
Iran J Biotechnol; 2024 Jan; 22(1):e3676. PubMed ID: 38827343
[TBL] [Abstract][Full Text] [Related]
46. Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches.
El-Shehawy AA; Elmetwalli A; El-Far AH; Mosallam SAE; Salama AF; Babalghith AO; Mahmoud MA; Mohany H; Gaber M; El-Sewedy T
BMC Complement Med Ther; 2023 Mar; 23(1):69. PubMed ID: 36870998
[TBL] [Abstract][Full Text] [Related]
47. The protective effect of thymoquinone over olanzapine-induced side effects in liver, and metabolic side effects.
Bilgic S; Tastemir Korkmaz D; Azirak S; Guvenc AN; Kocaman N; Ozer MK
Bratisl Lek Listy; 2017; 118(10):618-625. PubMed ID: 29198130
[TBL] [Abstract][Full Text] [Related]
48. Curcumin and Thymoquinone Combination Attenuates Breast Cancer Cell Lines' Progression.
El-Far AH; Saddiq AA; Mohamed SA; Almaghrabi OA; Mousa SA
Integr Cancer Ther; 2022; 21():15347354221099537. PubMed ID: 35583244
[TBL] [Abstract][Full Text] [Related]
49. Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone.
Mansour MA; Ginawi OT; El-Hadiyah T; El-Khatib AS; Al-Shabanah OA; Al-Sawaf HA
Res Commun Mol Pathol Pharmacol; 2001; 110(3-4):239-51. PubMed ID: 12760491
[TBL] [Abstract][Full Text] [Related]
50. Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD-L1 in Triple-Negative Breast Cancer Cells.
Adinew GM; Messeha SS; Taka E; Badisa RB; Soliman KFA
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432484
[TBL] [Abstract][Full Text] [Related]
51. Thymoquinone attenuates phosphorylation of AKT to inhibit kidney cancer cell proliferation.
Dera A; Rajagopalan P
J Food Biochem; 2019 Apr; 43(4):e12793. PubMed ID: 31353586
[TBL] [Abstract][Full Text] [Related]
52. Thymoquinone Enhances the Effect of Gamma Knife in B16-F10 Melanoma Through Inhibition of Phosphorylated STAT3.
Hatiboglu MA; Kocyigit A; Guler EM; Akdur K; Khan I; Nalli A; Karatas E; Tuzgen S
World Neurosurg; 2019 Aug; 128():e570-e581. PubMed ID: 31054338
[TBL] [Abstract][Full Text] [Related]
53. Pharmacotherapy with Thymoquinone Improved Pancreatic β-Cell Integrity and Functional Activity, Enhanced Islets Revascularization, and Alleviated Metabolic and Hepato-Renal Disturbances in Streptozotocin-Induced Diabetes in Rats.
El-Shemi AG; Kensara OA; Alsaegh A; Mukhtar MH
Pharmacology; 2018; 101(1-2):9-21. PubMed ID: 28926842
[TBL] [Abstract][Full Text] [Related]
54. Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD-L1 in MDA-MB-231 Triple-Negative Breast Cancer Cells.
Adinew G; Messeha SS; Badisa R; Taka E; Soliman KFA
FASEB J; 2022 May; 36 Suppl 1():. PubMed ID: 35723877
[TBL] [Abstract][Full Text] [Related]
55. The Effect of Thymoquinone on Nuclear Factor Kappa B Levels and Oxidative DNA Damage on Experimental Diabetic Rats.
Usta A; Dede S
Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S458-S461. PubMed ID: 29142399
[TBL] [Abstract][Full Text] [Related]
56. Dietary Thymoquinone Alone or Combined with Swimming Exercise Protect against Microcystin-LR-Induced Oxidative Injury in Mice.
Altyar AE; Bekhet AH; Kamel M; Albadrani GM; Kensara OA; Abdel-Daim MM
Evid Based Complement Alternat Med; 2023; 2023():5643861. PubMed ID: 36874614
[TBL] [Abstract][Full Text] [Related]
57. Thymoquinone (2-Isoprpyl-5-methyl-1, 4-benzoquinone) as a chemopreventive/anticancer agent: Chemistry and biological effects.
Ahmad A; Mishra RK; Vyawahare A; Kumar A; Rehman MU; Qamar W; Khan AQ; Khan R
Saudi Pharm J; 2019 Dec; 27(8):1113-1126. PubMed ID: 31885471
[TBL] [Abstract][Full Text] [Related]
58. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
59. Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma.
Houssein M; Fatfat M; Habli Z; Ghazal N; Moodad S; Khalife H; Khalil M; Gali-Muhtasib H
Life Sci; 2020 Jun; 251():117639. PubMed ID: 32272181
[TBL] [Abstract][Full Text] [Related]
60. Anticancer activity of thymoquinone against breast cancer cells: Mechanisms of action and delivery approaches.
Shabani H; Karami MH; Kolour J; Sayyahi Z; Parvin MA; Soghala S; Baghini SS; Mardasi M; Chopani A; Moulavi P; Farkhondeh T; Darroudi M; Kabiri M; Samarghandian S
Biomed Pharmacother; 2023 Sep; 165():114972. PubMed ID: 37481931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
